BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
S. 995, H.R. 2146 Bipartisan Congressional Trade Priorities and Accountability Act, regarding intellectual property rights in trade agreements and international negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Copyright/Patent/Trademark CPT
HR 9, the Innovation Act, regarding all biopharmaceutical related provisions. S. 1137, Protecting American Talent and Entrepreneurship Act, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Health Issues HCR
Labor, HHS Appropriations,regarding all biopharmaceutical related provisions. Agriculture Appropriations, regarding all biopharmaceutical related provisions. H.R. 1078, FDA Safety Over Sequestration Act, regarding all biopharmaceutical related provisions. No bill, raised awareness about atrial fibrillation and stroke prevention. H/R. 1101, Viral Hepatitis Testing Act, regarding all biopharmaceutical related provisions. H.R.6, 21st Century Cures Initiative and Senate Innovation for a Healthier America proposal, regarding all biopharmaceutical related provisions. No Bill, lobbied Congress on biosimilar issues including naming, labeling and interchangability.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Medicare/Medicaid MMM
H.R. 1416, Cancer Patient Protection Act, regarding all biopharmaceutical related provisions. H.R. 1190 and S. 41, Protecting Seniors' Access to Medicare Act, regarding all biopharmaceutical related provisions. H.R. 2, Medicare Access and CHIP Authorization Act, regarding all biopharmaceutical related provisions H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Budget/Appropriations BUD
S. Con. Res. 11, budget resolution, regarding all biopharmaceutical related provisions. H.R. 719, Continuing Appropriations Act,regarding all biopharmaceutical related provisions. H.R. 2029, Consolidates Appropriations Act, regarding all biopharmaceutical related provsions. H.R. 3762, Restoring America's Healthcare Freedom Reconciliation Act, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.